Literature DB >> 16186514

Charcot-Marie-Tooth disease impairs quality of life: why? And how do we improve it?

Michael E Shy, Michael R Rose.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16186514     DOI： 10.1212/01.wnl.0000181027.21574.df

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  13 in total

1.  Defining disability: development and validation of a mobility-Disability Severity Index (mDSI) in Charcot-Marie-tooth disease.

Authors:  Sindhu Ramchandren; Michael Shy; Eva Feldman; Ruth Carlos; Carly Siskind
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-08-25       Impact factor: 10.154

2.  Therapeutic strategies for the inherited neuropathies.

Authors:  Michael E Shy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Natural history of Charcot-Marie-Tooth 2: 2-year follow-up of muscle strength, walking ability and quality of life.

Authors:  Luca Padua; D Pareyson; I Aprile; T Cavallaro; D A Quattrone; N Rizzuto; G Vita; P Tonali; A Schenone
Journal:  Neurol Sci       Date:  2009-12-17       Impact factor: 3.307

4.  Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy.

Authors:  Alexandra N Scurry; Dante J Heredia; Cheng-Yuan Feng; Gregory B Gephart; Grant W Hennig; Thomas W Gould
Journal:  J Neuropathol Exp Neurol       Date:  2016-02-25       Impact factor: 3.685

5.  Efficacy of focal mechanic vibration treatment on balance in Charcot-Marie-Tooth 1A disease: a pilot study.

Authors:  Costanza Pazzaglia; F Camerota; M Germanotta; E Di Sipio; C Celletti; L Padua
Journal:  J Neurol       Date:  2016-05-13       Impact factor: 4.849

6.  Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study.

Authors:  L Padua; I Aprile; T Cavallaro; I Commodari; D Pareyson; A Quattrone; N Rizzuto; G Vita; P Tonali; A Schenone
Journal:  Neurol Sci       Date:  2008-07-09       Impact factor: 3.307

7.  Foot deformity in charcot marie tooth disease according to disease severity.

Authors:  So Young Joo; Byung-Ok Choi; Deog Young Kim; Soo Jin Jung; Sun Young Cho; Soo Jin Hwang
Journal:  Ann Rehabil Med       Date:  2011-08-31

8.  An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.

Authors:  Shahram Attarian; Jean-Michel Vallat; Laurent Magy; Benoît Funalot; Pierre-Marie Gonnaud; Arnaud Lacour; Yann Péréon; Odile Dubourg; Jean Pouget; Joëlle Micallef; Jérôme Franques; Marie-Noëlle Lefebvre; Karima Ghorab; Mahmoud Al-Moussawi; Vincent Tiffreau; Marguerite Preudhomme; Armelle Magot; Laurène Leclair-Visonneau; Tanya Stojkovic; Laura Bossi; Philippe Lehert; Walter Gilbert; Viviane Bertrand; Jonas Mandel; Aude Milet; Rodolphe Hajj; Lamia Boudiaf; Catherine Scart-Grès; Serguei Nabirotchkin; Mickael Guedj; Ilya Chumakov; Daniel Cohen
Journal:  Orphanet J Rare Dis       Date:  2014-12-18       Impact factor: 4.123

Review 9.  Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review.

Authors:  Joana L C Cordeiro; Wilson Marques; Jaime E C Hallak; Flávia L Osório
Journal:  ASN Neuro       Date:  2014-05-27       Impact factor: 4.146

Review 10.  Management of Charcot-Marie-Tooth disease: improving long-term care with a multidisciplinary approach.

Authors:  Donald McCorquodale; Evan M Pucillo; Nicholas E Johnson
Journal:  J Multidiscip Healthc       Date:  2016-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.